BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Liang Li, Hongyang Wang. Heterogeneity of liver cancer and personalized therapyCancer Letters 2016; 379(2): 191 doi: 10.1016/j.canlet.2015.07.018
2
Alexander E Giakoustidis, Dimitrios E Giakoustidis. Immunosuppression strategies in liver transplantation patient; patients with hepatocellular carcinomaImmunotherapy 2017; 9(2): 197 doi: 10.2217/imt-2016-0110
3
Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Luca Marzi, Carlo Saitta, Jean-Charles Nault, Rodolfo Sacco. The calm before the storm: a report from the International Liver Cancer Association Congress 2015 – part 2Future Oncology 2016; 12(3): 285 doi: 10.2217/fon.15.324
4
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, Devendra K. Agrawal. Cellular and molecular targets for the immunotherapy of hepatocellular carcinomaMolecular and Cellular Biochemistry 2018; 437(1-2): 13 doi: 10.1007/s11010-017-3092-z
5
Dhatri Madduru, Johny Ijaq, Sujata Dhar, Saumyadip Sarkar, Naresh Poondla, Partha S. Das, Silvia Vasquez, Prashanth Suravajhala. Systems Challenges of Hepatic Carcinomas: A ReviewJournal of Clinical and Experimental Hepatology 2019; 9(2): 233 doi: 10.1016/j.jceh.2018.05.002
6
Zejian Huang, Ning Zhang, Wenda Li, Jun Cao, Lei Zhang, Yajin Chen. Expression of CHODL in hepatocellular carcinoma affects invasion and migration of liver cancer cellsOncology Letters 2017; 13(2): 715 doi: 10.3892/ol.2016.5466
7
Joydeep Chakraborty, Eric Hilgenfeldt, Roniel Cabrera. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 175 doi: 10.1007/978-3-319-68082-8_10
8
Lili Wang, Yongxiang Yi, Dandan Yin, Zhenxian Zhou, Jing Fan, Wei Ye, Wei Zhao. Augmented CD3+CD8+ and CD3+CD56− cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumorCytotherapy 2016; 18(4): 581 doi: 10.1016/j.jcyt.2015.11.021
9
FEATURESAsia-Pacific Biotech News 2016; 20(04): 12 doi: 10.1142/S0219030316000252
10
So Young Yoo, Narayanasamy Badrinath, Hyun Young Woo, Jeong Heo. Oncolytic Virus-Based Immunotherapies for Hepatocellular CarcinomaMediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5198798
11
Zhaoxiong Ma, Hua He, Fumou Sun, Yao Xu, Xuequn Huang, Yuexing Ma, Hong Zhao, Yang Wang, Min Wang, Juan Zhang. Selective targeted delivery of doxorubicin via conjugating to anti-CD24 antibody results in enhanced antitumor potency for hepatocellular carcinoma both in vitro and in vivoJournal of Cancer Research and Clinical Oncology 2017; 143(10): 1929 doi: 10.1007/s00432-017-2436-0
12
Shinu Chacko, Subir Samanta. “Hepatocellular carcinoma: A life-threatening disease”Biomedicine & Pharmacotherapy 2016; 84: 1679 doi: 10.1016/j.biopha.2016.10.078
13
Marco Puzzoni, Nicola Silvestris, Francesco Leone, Riccardo Giampieri, Luca Faloppi, Laura Demurtas, Emanuela Dell’Aquila, Donatella Marino, Oronzo Brunetti, Silvio Ken Garattini, Elena Ongaro, Giorgio Astara, Laura Orgiano, Giuseppe Aprile, Daniele Santini, Mario Scartozzi. The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?Targeted Oncology 2016; 11(5): 593 doi: 10.1007/s11523-016-0437-6
14
Valerie Chew, Liyun Lai, Lu Pan, Chun Jye Lim, Juntao Li, Raymond Ong, Camillus Chua, Jing Yao Leong, Kiat Hon Lim, Han Chong Toh, Ser Yee Lee, Chung Yip Chan, Brian K. P. Goh, Alexander Chung, Pierce K. H. Chow, Salvatore Albani. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analysesProceedings of the National Academy of Sciences 2017; 114(29): E5900 doi: 10.1073/pnas.1706559114
15
Bingling Dai, Xianpeng Shi, Nan Ma, Weina Ma, Yanmin Zhang, Tianfeng Yang, Jie Zhang, Langchong He. HMQ-T-B10 induces human liver cell apoptosis by competitively targeting EphrinB2 and regulating its pathwayJournal of Cellular and Molecular Medicine 2018; 22(11): 5231 doi: 10.1111/jcmm.13729
16
Min Ding, Ying Wang, Jiachang Chi, Tao Wang, Xiaoyin Tang, Dan Cui, Qijun Qian, Bo Zhai, Beicheng Sun. Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 PatientsPLOS ONE 2016; 11(12): e0168798 doi: 10.1371/journal.pone.0168798
17
Jie Shen, Li-Feng Wang, Zheng-Yun Zou, Wei-Wei Kong, Jing Yan, Fan-Yan Meng, Fang-Jun Chen, Juan Du, Jie Shao, Qiu-Ping Xu, Hao-Zhen Ren, Ru-Tian Li, Jia Wei, Xiao-Ping Qian, Bao-Rui Liu. Phase I clinical study of personalized peptide vaccination combined with radiotherapy for advanced hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(29): 5395-5404 doi: 10.3748/wjg.v23.i29.5395